Lionel S. Breuillaud

Montreal, QC, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Corrigendum to "Progressive human-like tauopathy with downstream neurodegeneration and neurovascular compromise in a transgenic rat model" [Neurobiol of Disease 184 (2023),106227 / YNBDI_106227].

Corrigendum to "Progressive human-like tauopathy with downstream neurodegeneration and neurovascular compromise in a transgenic rat model" [Neurobiol of Disease 184 (2023),106227 / YNBDI_106227].

Journal: Neurobiology of disease

Published: September 23, 2023

Neuronal loss and inflammation preceding fibrillary tau pathology in a rat model with early human-like tauopathy.

Neuronal loss and inflammation preceding fibrillary tau pathology in a rat model with early human-like tauopathy.

Journal: Neurobiology of disease

Published: June 23, 2023

Progressive human-like tauopathy with downstream neurodegeneration and neurovascular compromise in a transgenic rat model.

Progressive human-like tauopathy with downstream neurodegeneration and neurovascular compromise in a transgenic rat model.

Journal: Neurobiology of disease

Published: May 02, 2023

Aβ43 levels determine the onset of pathological amyloid deposition.

Aβ43 levels determine the onset of pathological amyloid deposition.

Journal: The Journal of biological chemistry

Published: February 02, 2023

Late-long-term potentiation magnitude, but not Aβ levels and amyloid pathology, is associated with behavioral performance in a rat knock-in model of Alzheimer disease.

Late-long-term potentiation magnitude, but not Aβ levels and amyloid pathology, is associated with behavioral performance in a rat knock-in model of Alzheimer disease.

Journal: Frontiers in aging neuroscience

Published: September 09, 2022

TNF-α-mediated reduction in inhibitory neurotransmission precedes sporadic Alzheimer's disease pathology in young Trem2R47H rats.

TNF-α-mediated reduction in inhibitory neurotransmission precedes sporadic Alzheimer's disease pathology in young Trem2R47H rats.

Journal: The Journal of biological chemistry

Published: October 13, 2020

Brain-Derived Neurotrophic Factor in the Nucleus Accumbens Mediates Individual Differences in Behavioral Responses to a Natural, Social Reward.

Brain-Derived Neurotrophic Factor in the Nucleus Accumbens Mediates Individual Differences in Behavioral Responses to a Natural, Social Reward.

Journal: Molecular neurobiology

Published: March 19, 2019

Neuropathological changes and cognitive deficits in rats transgenic for human mutant tau recapitulate human tauopathy.

Neuropathological changes and cognitive deficits in rats transgenic for human mutant tau recapitulate human tauopathy.

Journal: Neurobiology of disease

Published: January 25, 2019

Rescue of Early bace-1 and Global DNA Demethylation by S-Adenosylmethionine Reduces Amyloid Pathology and Improves Cognition in an Alzheimer's Model.

Rescue of Early bace-1 and Global DNA Demethylation by S-Adenosylmethionine Reduces Amyloid Pathology and Improves Cognition in an Alzheimer's Model.

Journal: Scientific reports

Published: April 21, 2016

Involvement of the agmatinergic system in the depressive-like phenotype of the Crtc1 knockout mouse model of depression.

Involvement of the agmatinergic system in the depressive-like phenotype of the Crtc1 knockout mouse model of depression.

Journal: Translational psychiatry

Published: November 17, 2015

MAP kinase phosphatase 1 (MKP-1/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 inhibition.

MAP kinase phosphatase 1 (MKP-1/DUSP1) is neuroprotective in Huntington's disease via additive effects of JNK and p38 inhibition.

Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience

Published: February 09, 2013

Showing 1-11 of 11

Last Updated: 09/26/2026